Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alumis Inc. | 5,779,348 | 5,779,348 | 0 | $23.06M | $56.41M | 34.31% | +$33.35M |
| CG Oncology, Inc.(CGON) | 1,004,050 | 1,004,050 | 0 | $40.44M | $41.69M | 25.36% | +$1.25M |
| Disc Medicine, Inc.(IRON) | 299,069 | 299,069 | 0 | $19.76M | $23.75M | 14.45% | +$3.99M |
| Natera, Inc.(NTRA) | 0 | 67,356 | +67,356 | $0 | $15.43M | 9.39% | +$15.43M |
| Lyell Immunopharma, Inc.(LYEL) | 477,078 | 477,078 | 0 | $7.75M | $14.68M | 8.93% | +$6.94M |
| Hims & Hers Health, Inc.CL A(HIMS) | 273,151 | 273,151 | 0 | $15.49M | $8.87M | 5.39% | -$6.62M |
| Maze Therapeutics, Inc.(MAZE) | 86,291 | 86,291 | 0 | $2.24M | $3.58M | 2.17% | +$1.34M |